(Q35085312)

English

The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

reproducibility

1 reference

based on heuristic

inferred from title

9

object named as

Shashi Bhushan

0 references

21

object named as

Roberto Bolli

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Steven P Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Xian-Liang Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Yiru Guo

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Charles Steenbergen

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David J Lefer

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Rakesh C Kukreja

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Maiying Kong

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Qianhong Li

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Xiaoping Zhu

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Junjie Du

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Yibing Nong

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Heather L Stowers

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kazuhisa Kondo

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Gregory N Hunt

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Traci T Goodchild

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Adam Orr

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Carlos C Chang

18

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ramzi Ockaili

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Fadi N Salloum

20

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

11 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Circulation Research

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

572-586

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4329104/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Novel therapeutic strategies for cardioprotection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Policy: NIH plans to enhance reproducibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNI

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Cardioprotection: chances and challenges of its translation to the clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

The quantification of infarct size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Myocardial protection at a crossroads: the need for translation into clinical therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Demonstration of an early and a late phase of ischemic preconditioning in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

8 July 2018

Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

27 September 2018

Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

27 September 2018

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

27 September 2018

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

27 September 2018

Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329104

27 September 2018

Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of

1 reference

https://pubmed.ncbi.nlm.nih.gov/25499773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/25499773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/25499773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1161/CIRCRESAHA.116.305462

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35085312&oldid=1659700048"